Holding(s) in Company

Summary by AI BETAClose X

On 30-Oct-2026 (issuer notified 02-Nov-2026) Spreadex Ltd reported its holding in Crism Therapeutics reduced to 2,000,374 voting rights, comprising 2,000,000 direct votes (2.510700%) and 374 votes via cash‑settled CFD/Swap (0.000500%), a total of 2.511200%, down from a prior 3.536500% (a decline of 1.025300 percentage points), indicating a disposal or reduction in exposure that alters shareholder composition and free float.

Disclaimer*

UK 100

Latest directors dealings